This is the first case of a limited form of systemic sclerosis (ISSc) associated with acute congestive heart failure (CHF) and primary biliary cirrhosis (PBC). A 58-year-old woman with ISSc wasadmitted because of a suddenonset of C^HF.The intravenous administration of nitroglycerine and furosemide ameliorated the symptomsof CHFwithin 24 hours. She had both anticentromere antibodies and antip25 doublet/triplet antibodies to intrahepatic microsomes. Thallium scintigraphy at rest demonstrated significant perfusion defects in both the anteroseptal and inferior myocardium. A coronary angiogram revealed normal coronary arteries and no vasospasm was provoked by the intracoronary administration of acetylcholine. The present case indicates that minute care should thus be taken for the prevention of acute CHFeven in patients with a limited form of SSc when thallium per fusion defects are identified. (Internal Medicine 40: 73-76, 2001) 
Introduction
There are two major disease subsets in scleroderma, principally defined by the degree and extent of skin involvement (1) . Patients whose skin involvement is restricted to the fingers, hands, forearms, and face, have what is termed a limited form of systemic sclerosis (ISSc), and those with scleroderma involving the extremities and the trunk are considered to have a diffuse form of systemic sclerosis (dSSc). Serologic analyses differentiate these two subsets; anticentromere antibody (ACA) and antitopoisomerase I (Scl-70) antibody are closely associated with ISSc and dSSc, respectively (2) . Cardiac involvement is one of the most life-threatening features known to diminish the survival of patients with dSSc (3).
Some studies observed no significant difference in the nature and severity of cardiac involvement between the two forms of scleroderma (4, 5) . However, severe cardiac involvement, such as acute onset of cardiac congestion, has so far rarely been described in patients with ISSc (6). Weherein describe a patient with ISSc and primary biliary cirrhosis (PBC) whodeveloped sudden onset of congestive heart failure (CHF) associated with both conduction and rhythm disturbances.
Case Report
A 58-year-old womanwas admitted to our hospital, because of sudden dyspnea of two hours duration in June 1996. Two years earlier, this patient first noted Raynaud's phenomenon in her toes. She thereafter visited our outpatient clinic, and was given a diagnosis of ISSc based on the clinicopathological findings of the third and fourth digits on her left foot, and the presence ofACA.She had no calcinosis nor telangiectasia, but upper gastrointestinal tract roentgenogramrevealed lower esophageal hypomotility. She had been followed up without medication. One year earlier, she had mild increases of liver enzyme levels; aspartate aminotransferase (AST), 56 IU// (normal: 8-30); alanine aminotransferase (ALT), 50 (normal: 5-35). Seven monthsearlier, she also had a complete left bundle branch block (CLBBB) of unknown origin. She had no history of either smoking or ischemic heart disease.
On admission, her height was 152.0 cm; weight, 47.0 kg. Her temperature was 36.6°C; pulse, 104/min with irregular rhythm; blood pressure, 150/90 mmHg;respiratory rate, 34/ min. Jugular venous dilatations were noted. Athird heart sound was audible in the apex, and coarse crackles were heard in the bilateral lung fields. Her bilateral fingers were slightly sclerotic and pigmented. She had no other clinical manifestations, such as xerophthalmia and xerostomia. An arterial blood gas analysis under conditions of 5 //min oxygen administration via a face mask showed the following: pH, 7.403; PaCO2, 35.5 Torr; and PaO2, 50.6 Torr. A chest radiograph showed cardiomegaly (cardiothoracic ratio: 67.0%) with severe pulmonary congestion (Fig. 1 ). An electrocardio- Tests for antibodies to RNP, Scl-70, Jo-1, SS-A, SS-B, and dsDNAyielded negative results. Rheumatoid factor was 97 IU/ ml. A urinalysis revealed no abnormalities. She was therefore given a diagnosis of acute CHF. The intravenous administration of nitroglycerine and furosemide improved the symptoms of CHFwithin 24 hours. Thereafter, thallium scintigraphy at rest demonstrated significant perfusion defects on an early image in both the anteroseptal and inferior myocardium of the left ventricle (Fig. 3) . A coronary angiogram revealed no organic stenoses. The early image (A) revealed significant per fusion defects in anteroseptal and inferior myocardium, which had an incomplete redistribution on the delayed image (B).
167 mg/dl (normal: 14-63); serum ceruloplasmin, 44.1 mg/dl (normal: 2 1-33). Percutaneous liver biopsy specimens showed infiltration of mononuclear cells and moderate fibrosis in the enlarged portal area (Fig. 4) . Anti-p95 (originally designated as anti-Is) (7), anti-LKM (7), and antimitochondrial M2anti-gen (8) and antismooth muscle cell antibodies were all negative, but anti-p25 doublet/triplet (originally designated as anti-MM) (9) was positive at a titer of 1:1. After being discharged from the hospital, no recurrence of CHFhas been noted for three years while the patient has been treated with a regimen consisting of long-acting isosorbide dinitrate 40 mg/day, nilvadipine 8 mg/day, and methylprednisolone 6 mg/day. Repeated echocardiography revealed no significant change in right and left ventricular dimensions, functions, or estimated pulmonary artery pressure (20/13 mmHg). Liver aminotransferases was persistently slightly elevated (AST, 34 IU//, ALT, 28).
Discussion
Follansbee et al (6) reported that, in patients with dSSc, ventricular conduction disturbances, such as either CLBBB or bifascicular block (right bundle branch block with left anterior fascicular block), might be closely associated with a reduction of the left ventricular ejection fraction and advanced fibrosis of the myocardium. In the present case with ISSc, asymptomatic CLBBBpreceded the sudden onset of CHF. However, the patient's myocardial fibrosis was mild, if present, because the ejection fraction did not severely decrease. Pathological examinations in scleroderma heart disease demonstrated structural abnormalities in both the myocardiumand such conduction systems as the sinus node, AVnode, His bundle, or its branches, associated with widespread narrowing lesions of the small coronary arteries (but not the epicardial coronary arteries) in the myocardiumand the nutrient arteries of impulse formation and conduction (10). Bulkley et al (1 1) hypothesized that "myocardial Raynaud's phenomenon" may be responsible for the occurrence of contraction band necrosis and myocardial fibrosis as a result of sustained or repeated episodes of interrupted microcirculation, that are randomly distributed throughout the myocardium. The patient's perfusion defects on the early image of thallium scintigraphy (Fig.  3 ) and normal coronary angiograms might indicate the extent and severity of impaired microcirculation. The pathogenetic mechanism of acute CHF, in the present case, may be due to the impaired microcirculation associated with transient but severe vasospasms of small coronary arteries, thus provoking conduction and rhythm disturbances as well as cardiac dysfunction. Other causes for acute CHF,such as myocarditis and/ or pericarditis, were considered to be less likely based on the clinical course and findings of laboratory, radiological, and echocardiographical examinations.
Patients with SSc who have significant myocardial per fusion defects may therefore be at an increased risk of developing subsequent serious cardiac disease or sudden death (1 2). The present case indicates that minute care should thus also be taken for the prevention of acute CHFeven in the limited forms of SSc when thallium perfusion defects are identified in such patients. A high-risk group of patients with scleroderma heart disease should be controlled by the administration of vasodilator drugs (13) to improve the microcirculation. These treatments mayalso help prevent fibrosis of the myocardium. Antimitochondrial antibodies (AMA)are detected in the sera of 95% of patients with PBC, while ACAare found in 9-29% of patients with PBC (14) . The present patient also had antip25 doublet/triplet (originally designated as anti-MM) antibodies to intrahepatic microsomes. Takano et al (9) described that: 1) these antibodies were found in 30%of patients with PBC and in 87.5% of those with autoimmune hepatitis, and 2) corticosteroid therapy was mostly effective in the treatment of PBC patients with these antibodies.
